Planning Alternatives’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Planning Alternatives's VRTX Position: Q2 2026 in Review
Planning Alternatives reduced its Vertex Pharmaceuticals (VRTX) stake by 8.3% in Q2 2026, selling an estimated $21.3K and leaving 527 shares worth $262K. The position accounts for 0.03% of the portfolio, ranked #103.
Planning Alternatives first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Planning Alternatives held 527 shares of Vertex Pharmaceuticals worth $262K as of Q2 2026.
- Planning Alternatives sold 48 Vertex Pharmaceuticals shares in Q2 2026, an estimated $21.3K.
- Vertex Pharmaceuticals made up 0.03% of Planning Alternatives's portfolio in Q2 2026, its #103 holding.
- Planning Alternatives first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Planning Alternatives's 13F filing for Q2 2026, filed 12 Aug 2026.